NASDAQ:ITRM

Iterum Therapeutics (ITRM) Earnings Date, Estimates & Call Transcripts

$1.14

-0.05 (-3.81%)

(As of 05/26/2023 08:47 PM ET)

Compare

Today's Range: $1.13
▼
$1.22
50-Day Range: $0.94
▼
$1.34
52-Week Range: $0.60
▼
$7.02

Volume: 62,500 shs
Average Volume: 77,074 shs
Market Capitalization: $14.69 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Upcoming Earnings Date: Aug. 11Estimated
Actual EPS (Mar. 16): -$0.41 Beat By $0.81
Consensus EPS (Mar. 16): -$1.22
Last Year's Q1 EPS (3/28/2022): -$0.45

Earnings Per Share Revenue

ITRM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ITRM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Iterum Therapeutics Analyst Forecasts

Current Year EPS Consensus Estimate: $-3.31 EPS
Next Year EPS Consensus Estimate: $-3.08 EPS

ITRM Earnings Date and Information

Iterum Therapeutics last released its quarterly earnings results on March 16th, 2023. The reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.22) by $0.81. Iterum Therapeutics has generated ($4.17) earnings per share over the last year (($4.17) diluted earnings per share). Earnings for Iterum Therapeutics are expected to grow in the coming year, from ($3.31) to ($3.08) per share. Iterum Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 11th, 2023 based off prior year's report dates.

Iterum Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/11/2023 (Estimated)
3/16/2023	Q4 2022	($1.22)	($0.41)	+$0.81	($0.41)
11/10/2022	Q3 2022	($0.92)	($0.43)	+$0.49	$1.52
8/12/2022	Q2 2022	($0.90)	($0.45)	+$0.45	($0.30)
5/13/2022	Q1 2022	($0.60)	($0.45)	+$0.15	($0.04)
3/28/2022	Q4 2021		($0.45)	($0.45)	($0.04)
11/12/2021	9/30/2021	$1.80	$0.30	($1.50)	($0.08)
8/12/2021	6/30/2021	($0.90)	($0.60)	+$0.30	($0.12)
5/14/2021	3/31/2021	($0.60)	($0.75)	($0.15)	$0.71
3/11/2021	12/31/2020	($2.10)	($1.65)	+$0.45	$0.06
11/19/2020	9/30/2020	($5.70)	($9.00)	($3.30)	($0.08)
8/6/2020	6/30/2020	($12.15)	($12.00)	+$0.15	($0.80)
5/14/2020	3/31/2020	($20.10)	($13.50)	+$6.60	($0.72)
3/12/2020	12/31/2019	($25.50)	($23.85)	+$1.65	($1.59)
11/12/2019	Q3 2019	($24.1050)	($32.25)	($8.1450)	($2.15)	$0.28 million
8/14/2019	Q2 2019	($22.4550)	($28.9096)	($6.4546)	($1.93)	$0.27 million
5/14/2019	3/31/2019	($20.25)	($21.60)	($1.35)	($1.44)		$0.04 million
3/25/2019	Q4 2018	($38.25)	($17.85)	+$20.40	($0.66)	$0.20 million	$0.24 million
11/14/2018	Q3 2018	($29.55)	($18.60)	+$10.95	($0.71)		$0.25 million
8/14/2018	Q2 2018	($21.60)	($33.30)	($11.70)	($2.22)		$0.19 million

Iterum Therapeutics Earnings - Frequently Asked Questions

When is Iterum Therapeutics's earnings date?: Iterum Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 11th, 2023 based off last year's report dates. Learn more on ITRM's earnings history.
Did Iterum Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Iterum Therapeutics (NASDAQ:ITRM) reported ($0.41) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.22) by $0.81. Learn more on analysts' earnings estimate vs. ITRM's actual earnings.

How much profit does Iterum Therapeutics generate each year?: Iterum Therapeutics (NASDAQ:ITRM) has a recorded net income of -$44.43 million. ITRM has generated -$4.17 earnings per share over the last four quarters.
What is Iterum Therapeutics's EPS forecast for next year?: Iterum Therapeutics's earnings are expected to grow from ($3.31) per share to ($3.08) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:ITRM) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Iterum Therapeutics (ITRM) Earnings Date, Estimates & Call Transcripts

ITRM Earnings Estimates and Actuals by Quarter

ITRM Estimated and Actual Revenue by Quarter

Iterum Therapeutics Analyst Forecasts

ITRM Earnings Date and Information

Iterum Therapeutics Earnings History by Quarter

Iterum Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Iterum Therapeutics (ITRM) Earnings Date, Estimates & Call Transcripts

Earnings Summary

ITRM Earnings Estimates and Actuals by Quarter

ITRM Estimated and Actual Revenue by Quarter

Iterum Therapeutics Analyst Forecasts

ITRM Earnings Date and Information

Iterum Therapeutics Earnings History by Quarter

Iterum Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat